DrugDev to Promote Adoption of Innovative Technologies to Advance Clinical Study Efficiency at Prestigious Pharma and Biotech Industry Conferences in Q4

Melissa Easy, DrugDev Founder and President, SiteStart

DrugDev executives and subject matter experts will share best practices learned from over 2,000 clinical trials at top pharma and biotech events in Q4.

Executives and subject matter experts from DrugDev, a QuintilesIMS company, who enable the world’s most progressive pharma and biotech organizations to do more clinical trials will share best practices learned from over 2,000 clinical trials at top pharma and biotech events in Q4.

DrugDev will demonstrate DrugDev Spark™, the world’s first unified clinical operations suite which improves global trials from planning through closeout, with proven solutions including site selection and feasibility (featuring the DrugDev Golden Number universal identifier), site activation, eConsent, site payments, LMS, site engagement, document management and more.

2017 Global Site Solutions Summit | October 5-8, Boca Raton – October 5-8, Boca Raton – Summit faculty member Melissa “Liss” Easy, DrugDev founder and President, SiteStart will apply her passion for improving the site-patient relationship by judging entrants for the SCRS Site Patient Recruitment Innovation Award. Presentations will take place October 7, and the winner will be announced October 8. Liss also will participate in a panel discussion, “Stand Out in Site Identification,” on October 7, 3:00-4:00 pm. Liss founded DrugDev to bring sponsors, sites and patients together through better technology-driven solutions and services, and more open communication. Her honors include being named to the PharmaVOICE 100 and winning the Partnerships in Clinical Trials Woman of the Year award. And, see a demonstration of DrugDev Spark at Booth 406.

Article Source…

Leave a Reply

Your email address will not be published. Required fields are marked *